GlassScriptPhysician profile
Christine Kirlew
NPI 1851657399
$2,452.73
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35.20 · 2020: $464 · 2021: $799 · 2022: $676 · 2023: $479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $465 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $464.87 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $271.40 | 2020-2023 | Mounjaro |
| Pfizer INC. | $232.14 | 2020-2023 | |
| Abbott Laboratories | $188.15 | 2021-2022 | |
| Novo Nordisk INC | $149.20 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $142.30 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $141.56 | 2020-2021 | |
| Paratek Pharmaceuticals, INC. | $133.21 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $129.80 | 2022 | |
| Exact Sciences Corporation | $129.36 | 2023 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $112.24 | 2021-2023 | Breztri, Farxiga |
| Amgen INC. | $107.69 | 2019-2023 | Repatha, Prolia, Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $98.06 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $86.31 | 2020-2022 | |
| Biohaven Pharmaceuticals, INC. | $83.18 | 2020-2021 | |
| Glaxosmithkline, LLC. | $71.30 | 2021-2023 | Trelegy Ellipta |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $62.04 | 2021-2023 | |
| Eisai INC. | $49.40 | 2020 | |
| Medtronic, INC. | $45.82 | 2023 | Linq II |
| Gilead Sciences, INC. | $43.08 | 2020-2021 | |
| Radius Health, INC. | $39.94 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.82 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.24 | 2021 | |
| Amarin Pharma, INC. | $16.87 | 2021 | |
| Upsher-Smith Laboratories LLC | $16.70 | 2022 | |
| Therapeuticsmd, INC. | $15.37 | 2021 | |
| Bausch Health US, LLC | $12.24 | 2021 | |
| Dermira, INC. | $11.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Kirlew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.